A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
Authors: P. S. Aisen, D. Saumier, R. Briand, J. Laurin, F. Gervais, P. Tremblay, D. Garceau
Institution: Georgetown University Medical Center
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2070880671
